GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Osteopore OSX.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.00

—

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in AUD, from our data supplier.

FY2025

Revenue

A$3.1m

FY2016FY2025

Net income

−A$3.7m

FY2016FY2025

Free cash flow

−A$2.6m

FY2016FY2025

Shareholders' equity

−A$1.7m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueA$3.1mA$2.8mA$2.2mA$1.7mA$1.1mA$1.5mA$414,058A$934,878A$610,620A$204,768
Research and developmentA$1.5mA$1.1mA$1.6mA$1.4m——————
Operating income−A$3.4m−A$2.9m−A$4.9m−A$4.2m−A$3.9m−A$2.6m−A$2.4m−A$901,940−A$528,880−A$1.1m
Net income−A$3.7m−A$3.4m−A$4.9m−A$4.2m−A$3.6m−A$1.9m−A$2.4m−A$870,249−A$446,975−A$972,768
Diluted earnings per share-0.02-0.03-0.47-0.05-0.03-0.05-0.08-0.02-0.01-0.03

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsA$2.8mA$3.1mA$3.3mA$3.6mA$6.0mA$10.2mA$4.3mA$5.4mA$349,607A$858,802
Cash and short-term investmentsA$626,972A$638,498A$1.2mA$2.2mA$5.1mA$9.0mA$3.3mA$5.0mA$33,783A$28,920
Total liabilitiesA$4.5mA$2.8mA$2.9mA$1.5mA$633,400A$1.3mA$1.3mA$1.2mA$2.2mA$2.2m
DebtA$198,800A$1.3mA$1.1mA$74,179A$148,840A$453,993A$596,564A$665,795A$510,214A$209,300
Shareholders' equity−A$1.7mA$306,220A$432,603A$2.1mA$5.4mA$9.0mA$3.0mA$4.2m−A$1.8m−A$1.4m
Shares outstanding189m102m10m83m117m41m29m38m38m38m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−A$2.6m−A$3.1m−A$3.7m−A$4.0m−A$3.8m−A$1.8m−A$1.7m−A$334,116A$11,163−A$184,273
Capital spending−A$10,792−A$14,590−A$7,365−A$63,975−A$194,616−A$381,044−A$78,338−A$66,508−A$49,192−A$73,623
Free cash flow−A$2.6m−A$3.1m−A$3.7m−A$4.1m−A$4.0m−A$2.1m−A$1.8m−A$400,624−A$38,029−A$257,896
Dividends paid———−A$48,681——————

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Sept 2023Jun 2023
RevenueA$1.4mA$1.5mA$1.6mA$1.3mA$1.5mA$1.2mA$610,154A$997,102
Operating income−A$1.3m−A$1.6m−A$1.4m−A$1.7m−A$1.4m−A$1.9m−A$926,481−A$2.9m
Net income−A$2.0m−A$2.1m−A$1.6m−A$1.6m−A$1.6m−A$1.9m−A$947,112−A$3.0m
Diluted earnings per share-0.00-0.01-0.01-0.02-0.02-0.18-0.09-0.29
Cash from operations—−A$1.0m−A$1.0m−A$1.0m−A$1.0m−A$1.0m—−A$1.0m
Total assetsA$3.4mA$2.8mA$4.2mA$3.1mA$4.5mA$3.3mA$3.3mA$5.0m
Cash and short-term investmentsA$1.3mA$626,972A$1.8mA$638,498A$2.2mA$1.1mA$1.2mA$1.9m
DebtA$65,854A$1.6mA$1.7mA$1.3mA$1.1mA$1.1mA$1.1mA$48,501
Shareholders' equity−A$1.8m−A$1.7m−A$423,652A$306,220A$1.8mA$432,603A$432,603A$2.3m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue21.8%15.2%—
Operating income-6.6%5.4%—
Net income-4.1%13.9%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Price to earnings-0.3-1.1-0.1-1.9-4.8-7.3-5.9
Price to sales0.41.30.14.915.69.434.1

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 15-to-1 reverse split · 23 Feb 2024

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.